How much does a box of imported lenalidomide 25mg cost?

Lenalidomide (Lenalidomide) is an oral drug that belongs to the category of immunomodulators. It is widely used to treat multiple myeloma (MM), myelodysplastic syndromes (Melodysplastic Syndromes, MDS) and lymphoproliferative diseases (Lymhoproliferative Disorders) and other hematological malignancies.

Lenalidomide is now available in China and is covered by medical insurance. Patients can purchase it in the domestic market at a price of approximately 4,000 to 5,000 yuan. For specific prices and medical insurance reimbursement details, please consult the local hospital pharmacy.

In addition, there are more affordable generic lenalidomide drugs on the foreign market, such as those produced in Laos, Bangladesh and India, and the price is only a few hundred yuan. It is worth mentioning that the ingredients of these foreign generic drugs are basically the same as those of domestic original drugs.

Lenalidomide can inhibit the proliferation of tumor cells, slow down the growth and spread of tumors, thereby effectively controlling the progression of the disease. It can induce apoptosis in tumor cells, accelerate the death of abnormal cells, and help reduce the number of malignant tumor cells. Lenalidomide also has the effect of regulating the immune system, enhancing the body's immune response, increasing the activity of natural killer cells (NK cells), and increasing the ability to clear tumor cells. It can inhibit the formation of new blood vessels around tumor cells and block the blood supply to tumors, thereby limiting tumor growth and metastasis.

Lenalidomide is usually given as part of long-term treatment, either as monotherapy or in combination with other drugs. In clinical practice, it has been proven to be an effective therapeutic drug that can significantly improve patients' symptoms, prolong survival, and improve quality of life. However, the use of lenalidomide may cause a series of adverse reactions, including anemia, gastrointestinal discomfort, skin reactions, etc., so close monitoring and management are required during use. Despite this, lenalidomide is still considered one of the important drugs for the treatment of hematological malignancies, providing patients with new treatment options and hope.